Monolithic Power Systems reported quarterly earnings of $4.21 per share which beat the analyst consensus estimate of $4.11 ...

Of the 30 companies in the index, 20 firms saw their stock price decline, eight saw their share price increase, and two were flat month over month.

Fulgent Genetics (FLGT) delivered earnings and revenue surprises of +130.43% and +7.80%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Fulgent Genetics ranks at the bottom for Revenue Growth and Gross Profit, with negative percentages. It is also at the bottom for Return on Equity, with a negative percentage. Overall, Fulgent ...

Detailed price information for Fulgent Genetics Inc (FLGT-Q) from The Globe and Mail including charting and trades.

FLGT Investors Have Opportunity to Join Fulgent Genetics, Inc. Fraud Investigation with the Schall Law Firm ...

Fulgent Genetics is a biotech company with a profitable COVID-19 diagnostics segment that will be negligible going forward. Read why I rate FLGT stock a Buy.

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at where Fulgent Genetics, Inc.

Fulgent Genetics (NASDAQ: FLGT) just reported results for the first quarter of 2024. Fulgent Genetics reported earnings per share of -1 cent. This was above the analyst estimate for EPS of -32 cents.

In a report released today, Andrew Cooper from Raymond James maintained a Buy rating on Fulgent Genetics (FLGT – Research Report). The company’s shares closed yesterday at $32.79.